Lamivudine monotherapy in HBeAg-negative chronic hepatitis B: prediction of response-breakthrough and long-term clinical outcome.
Manolakopoulos S, Bethanis S, Elefsiniotis J, Karatapanis S, Triantos C, Sourvinos G, Touloumi G, Economou M, Vlachogiannakos J, Spandidos D, Avgerinos A, Tzourmakliotis D.
Manolakopoulos S, et al. Among authors: economou m.
Aliment Pharmacol Ther. 2006 Mar 15;23(6):787-95. doi: 10.1111/j.1365-2036.2006.02806.x.
Aliment Pharmacol Ther. 2006.
PMID: 16556181
Free article.